Sabra Health Care REIT, Inc.
SBRA
$19.28
-$0.23-1.18%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -0.31% | 2.52% | 3.65% | 1.39% | -2.09% |
| Total Other Revenue | 21.63% | 20.56% | 20.60% | 20.01% | 69.71% |
| Total Revenue | 9.47% | 10.35% | 10.90% | 9.14% | 20.68% |
| Cost of Revenue | 15.35% | 15.24% | 15.33% | 16.01% | 14.04% |
| Gross Profit | 6.75% | 8.14% | 8.90% | 6.15% | 24.04% |
| SG&A Expenses | -5.36% | -2.67% | 4.19% | 5.47% | 28.98% |
| Depreciation & Amortization | 4.53% | 0.82% | -1.72% | -7.35% | -10.49% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.95% | 7.35% | 7.08% | 4.79% | 4.45% |
| Operating Income | 10.42% | 15.82% | 18.04% | 17.61% | 68.05% |
| Income Before Tax | 79.86% | 238.78% | 176.68% | 710.49% | 213.35% |
| Income Tax Expenses | 54.38% | -44.23% | -44.12% | -49.80% | -31.54% |
| Earnings from Continuing Operations | 80.15% | 248.73% | 184.38% | 821.14% | 209.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 80.17% | 248.73% | 184.38% | 821.14% | 209.99% |
| EBIT | 10.42% | 15.82% | 18.04% | 17.61% | 68.05% |
| EBITDA | 8.34% | 9.90% | 9.86% | 6.57% | 24.14% |
| EPS Basic | 76.02% | 240.70% | 179.29% | 809.92% | 209.33% |
| Normalized Basic EPS | 30.57% | 42.54% | 35.73% | 35.82% | 347.27% |
| EPS Diluted | 78.62% | 264.11% | 197.25% | 995.29% | 204.07% |
| Normalized Diluted EPS | 30.19% | 41.81% | 34.96% | 34.79% | 344.71% |
| Average Basic Shares Outstanding | 2.56% | 2.29% | 1.65% | 0.99% | 0.43% |
| Average Diluted Shares Outstanding | 2.89% | 2.83% | 2.23% | 1.72% | 1.27% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -0.43% | -0.71% | -0.64% | -0.89% | 1.91% |